LBA44 Primary results of a randomized phase II study of osimertinib plus bevacizumab versus osimertinib monotherapy for untreated patients with non-squamous non-small cell lung cancer harboring EGFR mutations: WJOG9717L studyHirotsugu Kenmotsu, Toshiaki Takahashi, Kazushige Wakuda et al.|Annals of Oncology|2021Cited by 17
P2.23-02 Prospective Observational Study of Cachexia and Its Effect on Systemic Therapy in Patients with Previously-Untreated Advanced NSCLC (NEJ050A)Naoki Furuya, K. Takahashi, Kiyonori Miura et al.|Journal of Thoracic Oncology|2023Cited by 2
Status Report of the Operation of the RIKEN AVF CyclotronK. Suda, Yamaka Shoichi, Misaki Komiyama et al.|JACOW|2016Cited by 0
Status Report on the Operation of the RIBF Ring CyclotronsKazutaka Ozeki, H. Yamasawa, Tomoyuki Dantsuka et al.|JACOW|2016Cited by 0
Sarcomatoid Carcinoma in a Resected Hepatic Metastasis of Esophageal Squamous Cell Carcinoma after ChemotherapyKotaro Kimura, Yuko Omori, Kentaro Kato et al.|Surgical Case Reports|2025Cited by 0